Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network

The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network

Resource Type

CF Research News

Authors

Kelsie Pearson, Nicole Mayer-Hamblett, Christopher H Goss, George Z Retsch-Bogart, Jill M VanDalfsen, Patricia Burks, Daniel Rosenbluth, John Paul Clancy, Amy Hoffman, David P Nichols

References

J Cyst Fibros. 2020 Dec 15;S1569-1993(20)30939-5. doi: 10.1016/j.jcf.2020.12.007.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Clinical research [3]
Coronavirus [4]
SARS-CoV-2 [5]

Date

Tuesday, December 15, 2020

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/impact-sars-cov-2-cystic-fibrosis-foundation-therapeutics

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-20-00487R1_FINAL_Pearson_260121.pdf [2] https://pubmed.ncbi.nlm.nih.gov/33349583/ [3] https://www.ecfs.eu/research-article-keywords/clinical-research [4] https://www.ecfs.eu/research-article-keywords/coronavirus [5] https://www.ecfs.eu/research-article-keywords/sars-cov-2 [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines